EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway

Ying Li, Lei Wang, Tianyue Guan, Yaru Chen, Wenting Zhu, Xiao Liu, Yusa Li, Hongyu Huang, Zibo Dong, Honggang Zhang

Inflammation · 2025

DOI: 10.1007/s10753-025-02403-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2025. Verfasst von Ying Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang Clinical College of Nanjing Medical Uni…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, rhoA GTP-Binding Protein, MAP Kinase Signaling System, Alkaloids. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lianyungang First People's Hospital Doctoral Initiation Fund, Jiangsu Provincial Health Commission, Lianyungang City Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic cardiomyopathy (DCM) is a major complication of diabetes, characterized by myocardial inflammation, oxidative stress, fibrosis, apoptosis, and RhoA activation, ultimately leading to heart failure. This study aimed to evaluate whether higenamine hydrochloride (HGN), a natural alkaloid with anti-inflammatory and antioxidant properties, could alleviate DCM and elucidate its underlying mechanisms. A DCM model was established via streptozotocin injection in mice, followed by HGN administration. Fasudil, a RhoA inhibitor, was used to assess pathway involvement. Histology, biochemical assays, flow cytometry, immunoblotting, ELISA, and qPCR were employed for evaluation. Results showed that HGN effectively alleviated cardiac histological abnormalities and myocardial injury in DCM mice. Further analysis revealed that HGN attenuated DCM-induced cardiac inflammation, oxidative stress, fibrosis, and apoptosis (p < 0.05). In vitro, HGN also reduced high glucose-induced inflammation, oxidative stress, fibrosis, and apoptosis in H9C2 cardiomyocytes (p < 0.05). Mechanistically, these protective effects were mediated by inhibition of RhoA, through which HGN suppressed the MEK/ERK signalling pathway, thereby mitigating cardiomyocyte injury (p < 0.05). However, the RhoA inhibitor fasudil hydrochloride abolished the cardioprotective effects of HGN in DCM mice, specifically, fasudil hydrochloride reversed the HGN-induced improvements in cTnT, CK, and LDH levels. Additionally, echocardiographic parameters (IVSD, LVPWd, LVPWs, LVIDd, LVIDs, IVSs, EF, and FS) were also reversed to levels seen in untreated DCM mice, further confirming that HGN exerts its therapeutic actions via the RhoA/MEK/ERK axis (p < 0.05). Overall, HGN mitigates cardiac inflammation, oxidative stress, fibrosis, and apoptosis in DCM by inhibiting the MEK/ERK pathway through RhoA. This study provides a scientific basis for developing DCM treatments and highlights the therapeutic potential of HGN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesrhoA GTP-Binding ProteinMAP Kinase Signaling SystemAlkaloidsTetrahydroisoquinolinesrho GTP-Binding ProteinsAnimalsMiceOxidative StressMaleApoptosisDiabetes Mellitus, ExperimentalMyocytes, CardiacRatsMice, Inbred C57BL

Stichwörter der Autor:innen

Heart damageHigenamine hydrochlorideMEK/ERKRhoAType i diabetes mellitus

Substanzen

higenaminerhoA GTP-Binding ProteinAlkaloidsTetrahydroisoquinolinesRhoA protein, mouserho GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Vascular Surgery, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, 2220…
  • Jiangsu Marine Pharmaceutical Resources Development Engineering Research Center, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, College of Pharmacy, Jiangsu Ocean University, Lianyungang, 222005, Ch…
  • Department of Laboratory Medicine, Central Laboratory, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang Clinical College of Nanjing Medical University, The First People's Hospital of Lianyun…

Förderung

  • Lianyungang First People's Hospital Doctoral Initiation Fund
  • Jiangsu Provincial Health Commission
  • Lianyungang City Science and Technology Plan Project

Zitieren

APA

Li, Y., Wang, L., Guan, T., Chen, Y., Zhu, W., Liu, X., Li, Y., Huang, H., Dong, Z., & Zhang, H. (2025). Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway. Inflammation. https://doi.org/10.1007/s10753-025-02403-4

Vancouver

Li Y, Wang L, Guan T, Chen Y, Zhu W, Liu X, et al. Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway. Inflammation. 2025. doi:10.1007/s10753-025-02403-4

BibTeX
@article{Li2025,
  author = {Li, Ying and Wang, Lei and Guan, Tianyue and Chen, Yaru and Zhu, Wenting and Liu, Xiao and Li, Yusa and Huang, Hongyu and Dong, Zibo and Zhang, Honggang},
  title = {Higenamine Hydrochloride Ameliorates Diabetic Cardiomyopathy Through RhoA/MEK/ERK Pathway},
  journal = {Inflammation},
  year = {2025},
  doi = {10.1007/s10753-025-02403-4}
}
Kostenlos starten →